Clinical trial • Enrolling • 18 October 2011
A randomised, open-label study to evaluate the efficacy and safety of maraviroc (MVC) as a switch for either nucleoside or nucleotide analogue reverse transcriptase inhibitors (N(t)RTI) or boosted protease inhibitors (PI/r) in HIV-1 infected individuals with stable, well-controlled plasma HIV-RNA while taking their first N(t)RTI + PI/r regimen of combination antiretroviral therapy (cART)
Clinical trial • Enrolling • 12 February 2013
Improving antiretroviral treatment (ART) initiation for people living with HIV in Australia: a realistic and viable approach? Sub-study 3: interviewing people diagnosed with HIV currently not on ART.
Tags: Understanding HIV treatments, living with HIV, starting treatments
Clinical trial • Enrolling • 11 February 2013
Clinical trial • Enrolling • 24 March 2011
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir-boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)-Naive Adults
Tags: heart disease
Clinical trial • Enrolling • 9 April 2009
Strategic Timing of AntiRetroviral Treatment (START)
Tags: starting treatments
Clinical trial • Enrolling • 7 February 2012
A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
Clinical trial • Enrolling • 23 November 2011
Effectiveness of Team Intervention Over 12 Months in Reducing Modifiable CVD Risk Factors on Framingham 10yr Risk Scores Outcomes in HIV-1 Subjects on Antiretroviral Therapy
Clinical trial • Enrolling • 19 February 2010
The Evaluation of the Impacts of a Doctor – Pharmacist Collaborative Prescribing Model on the Management of Human Immunodeficiency Virus (HIV) Infected Patients
Tags: Accessing HIV care and treatment
Clinical trial • Enrolling • 19 February 2010
A prospective cohort study of individuals with primary Human Immunodefiency Virus (HIV) infection to determine immunological and virological factors related to disease progression.
Tags: pathogenesis
Clinical trial • Unknown • 19 February 2010
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
Tags: hepatitis B
Clinical trial • Not yet started • 22 October 2008
A Randomized, Multicenter Trial to Determine Whether Induction Therapy Followed by Treatment Interruption is Superior to Induction Therapy Alone in the Treatment of Primary HIV Infection (PHI): The Structured Treatment Interruption (STI) Study
Clinical trial • Enrolling • 11 May 2007
Predictors of Drug Hypersensitivity in HIV-infected subjects
Tags: hypersensitivity reactions
Clinical trial • Enrolling • 11 May 2007
Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) co-Infection and Liver Disease
Tags: hepatitis B, liver disorders
Clinical trial • Enrolling • 28 March 2008
A surveillance program for the detection of hepatitis B virus (HBV) resistance to tenofovir (TDF) in HIV-HBV co-infected patients
Tags: hepatitis B
This site complies with the HONcode standard for trustworthy health information: verify here. 